PEAK DIAGNOSTIC PARTNERS LLC
Westminster, CO · Medtech · Private
Next-generation sequencing (NGS) diagnostic panel for detecting microbial pathogens, antimicrobial resistance, and host immune response in respiratory infections
peakdxpartners.com →- Grants
- $3.6M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20192020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Enabling comprehensive diagnosis of sub-acute infection in chronic respiratory disease via high sensitivity next generation sequencing | $299,999 | |
| Federal grant | Department of Health and Human Services · Phase II · Enabling comprehensive diagnosis of sub-acute infection in chronic respiratory disease via high sensitivity next generation sequencing | $2,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Enabling comprehensive diagnosis of sub-acute infection in chronic respiratory disease via high sensitivity next generation sequencing | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase I · A comprehensive next generation sequencing diagnostic tool for lung infection among hospitalized patients | $300,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1612 | Buck Surgical, Inc. | — | $300K |
| 1613 | NeoTherma Oncology Inc. | — | — |
| 1614 | VYLUMA INC. | — | — |
| 1615 | PEAK DIAGNOSTIC PARTNERS LLC | — | — |
| 1616 | Eye To Eye Telehealth, Inc. | — | $1.0M |
| 1617 | PROPEL ORTHODONTICS, LLC | — | — |
| 1618 | ORTHO HAUS LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.